Press release
Quadrivalent Vaccines Is A Crucial Strategy In Combating The Dual Burden Of Chronic And Infectious Diseases: An Emerging Driver Transforming The Quadrivalent Market Landscape
Quadrivalent
What Is the Quadrivalent Market Size and Projected Growth Rate?
In the past few years, the quadrivalent market experienced significant growth. Its size is projected to increase from $8.87 billion in 2024 to $9.61 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.2%. The previously observed growth could be attributed to factors such as disease intricacy, educational schemes, historical health incidents, expansion in healthcare, and technological advancements.
The market size for the quadrivalent is projected to experience swift expansion over the coming years, reaching a value of $14.22 billion in the year 2029 with a Compound Annual Growth Rate (CAGR) of 10.3%. Several factors will contribute to this growth during the forecast period, including global health occurrences, the competitive nature of the market, educational initiatives, changes in regulations, and changing disease patterns. Key trends expected in the forecast period involve disease prevalence, regulatory climate, the state of healthcare infrastructure, the level of consumer awareness and education, and the competitive environment.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9335
What Are the Different Quadrivalent Market Segments?
The quadrivalent market covered in this report is segmented -
1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray
2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)
Subsegments:
1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery
2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection
3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp
What Are the Primary Drivers Shaping the Quadrivalent Market?
The growth of the quadrivalent market is anticipated to be accelerated by the increasing prevalence of chronic and infectious diseases. Chronic diseases, which are long-lasting illnesses often caused by genetic factors and lifestyle choices, along with infectious diseases caused by infectious agents such as viruses, bacteria, fungi, and protozoa, significantly impact global health. Quadrivalent vaccines play a critical role in reducing the severity and death rate from severe infections and diseases that are not necessarily the prime focus of these vaccines. They are also utilized in preventing chronic (non-communicable) conditions where infectious agents contribute to their development. For example, the Centers for Disease Control and Prevention, a non-profit organization based in the US, reported in September 2024 (Week 37) that 0.5% of specimens tested positive for influenza, with 91.4% being influenza A and 8.6% influenza B. Moreover, since October 1, 2023 (Week 40), the overall positivity rate was determined to be 8.7%, with 69.2% being influenza A and 30.8% influenza B, suggesting a rising overall positivity rate and a steady increase in the proportionate of influenza B cases over time. Therefore, the mounting prevalence of chronic and infectious diseases is a major driver for the quadrivalent market's expansion.
Which Companies Are Leading in the Quadrivalent Market?
Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)
What Are the Major Trends Shaping the Quadrivalent Market?
The emergence of product innovations is a leading trend rising in prominence within the quadrivalent sector. Major corporations engaged in the quadrivalent industry are concentrating on crafting groundbreaking solutions, an effort aimed at fortifying their market standing. To illustrate, AstraZeneca, a pharmaceutical organization based in the UK, introduced FluMist quadrivalent (Influenza Vaccination Live, Intranasal) in September 2022. This FDA-approved flu vaccination for individuals aged 2 to 49 is deployed via a needle-free nasal spray. It's a live attenuated influenza vaccine (LAIV) and comes in either trivalent or quadrivalent formula versions. Most health insurance plans cover it, and it's also included in the children's vaccination program.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report
What Are the Top Revenue-Generating Geographies in the Quadrivalent Market?
North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Quadrivalent Market?
2. What is the CAGR expected in the Quadrivalent Market?
3. What Are the Key Innovations Transforming the Quadrivalent Industry?
4. Which Region Is Leading the Quadrivalent Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Quadrivalent Vaccines Is A Crucial Strategy In Combating The Dual Burden Of Chronic And Infectious Diseases: An Emerging Driver Transforming The Quadrivalent Market Landscape here
News-ID: 3983124 • Views: …
More Releases from The Business Research Company
Booming Construction Activity Drives Growth of the Voice Gender Conversion Artif …
What Will the Voice Gender Conversion Artificial Intelligence (AI) Market Size Reach by 2025?
The sphere of artificial intelligence dedicated to voice gender conversion has witnessed remarkable, rapid expansion lately, projected to ascend from a valuation of $1.06 billion in 2024 to $1.33 billion the following year, exhibiting a compound annual growth rate of 25.5%. This historical upward trajectory is fueled significantly by the wider integration of AI within the media…
Future of the Vertical Video Templates Marketplaces Market: Key Innovations and …
What Market Value Will the Vertical Video Templates Marketplaces Industry Achieve by 2025?
The market for vertical video templates has experienced substantial expansion lately, projected to move from a valuation of $1.24 billion in the year 2024 to reach $1.45 billion by 2025, reflecting a compound annual growth rate (CAGR) of 16.7%. This historical upward trajectory is primarily fueled by several key factors: a widespread embrace of brief video formats, the…
Global Vector Index Freshness Management Market Expected to Grow at 22.5% CAGR, …
What Will the Vector Index Freshness Management Market Size Reach by 2025?
The market valuation for vector index freshness management has experienced rapid expansion lately, escalating from a figure of $1.35 billion in 2024 to an anticipated $1.65 billion just one year later in 2025, reflecting a compound annual growth rate (CAGR) of 22.8%; this substantial historical uplift is primarily fueled by the amplified deployment of large language models, heightened attention…
2025-2034 User-Generated Content Rights Platform Market Evolution: Emerging Oppo …
"What Is the Projected Size of the User-Generated Content Rights Platform Market by 2025?
The market encompassing platforms for user-generated content rights has seen rapid expansion lately, projected to increase its valuation from 1.74 billion US dollars in 2024 to 2.15 billion US dollars the subsequent year, reflecting a compound annual growth rate (CAGR) of 23.3%. This historical expansion primarily stems from several contributing factors, notably the surge in digitally produced…
More Releases for Quadrivalent
Quadrivalent Vaccines Is A Crucial Strategy In Combating The Dual Burden Of Chro …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Quadrivalent Market Through 2025?
The market size of the quadrivalent has exhibited vigorous growth in the past few years. It is projected to increase from $8.87 billion in 2024 to $9.61 billion in 2025, showing a compound annual growth rate (CAGR) of 8.2%. Factors such as the…
Afluria Quadrivalent Industry Report 2025-2034: Market Dynamics, Drivers, And Fo …
The Afluria Quadrivalent Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Afluria Quadrivalent Market?
The size of the afluria quadrivalent market has seen a HCAGR of XX over recent years. Projected growth is from $XX million in 2024 to…
Impact Of Rising Influenza Prevalence On The Growth Of The Afluria Quadrivalent …
What Are the Projected Growth and Market Size Trends for the Afluria Quadrivalent Market?
The market size for afluria quadrivalent has witnessed a Compound Annual Growth Rate of $XX in the past few years. Forecasts predict an escalation from a worth of $XX million in 2024 to $XX million in 2025, positing a Compound Annual Growth Rate (CAGR) of $XX%. The growth experienced in the previous duration has occurred due to…
Quadrivalent Flu Vaccine Market Analysis 2019 and Industry Insights in the Futur …
QY Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the global Quadrivalent Flu Vaccine market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts.
Request a Sample of this report at
http://www.qyresearchglobal.com/goods-1899719.html
Key Manufacturers:
…
Influenza Vaccine Market to See Worldwide Growth by 2025: Leading Companies Fluz …
A report added to the rich database of Qurate Business Intelligence, titled “Influenza Vaccine Market Size, Status and Forecast 2025”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data reliable in context to…
The U.S. Flu Vaccine Market Size and Outlook | Focus on Major Flu Vaccines such …
The U.S. Flu Vaccine Market Research Report Description:
Ricerca Alfa, a leading market research firm recently collated a novel report on Flu Vaccine market. The report states that the Flu Vaccine Market is expected to reach approximately US$ 3 billion by the year 2024. The report also presents detailed key factors such as flu vaccine production, price, supply, demand, effectiveness, and many more. The research report encompasses current pricing trends (adult…
